BRIDGEWAY CAPITAL MANAGEMENT, LLC - ADAMAS PHARMACEUTICALS INC ownership

ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 100 filers reported holding ADAMAS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 2.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of ADAMAS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$564,000
-59.7%
114,900
-56.6%
0.01%
-56.0%
Q2 2021$1,399,000
+61.9%
264,900
+47.2%
0.02%
+56.2%
Q1 2021$864,000
+53.7%
179,900
+38.5%
0.02%
+33.3%
Q4 2020$562,000
+9.1%
129,900
+3.9%
0.01%0.0%
Q3 2020$515,000
+8.6%
125,000
-32.4%
0.01%
+20.0%
Q2 2020$474,000
+72.4%
185,000
+94.7%
0.01%
+66.7%
Q1 2020$275,000
-36.9%
95,000
-17.4%
0.01%0.0%
Q4 2019$436,000
-25.9%
115,0000.0%0.01%
-25.0%
Q3 2019$588,000
-17.5%
115,0000.0%0.01%
-11.1%
Q2 2019$713,000
-30.8%
115,000
-20.7%
0.01%
-30.8%
Q1 2019$1,031,000145,0000.01%
Other shareholders

There were no reported owners of ADAMAS PHARMACEUTICALS INC in Q1 2019.

NameSharesValueWeighting ↓
View complete list of ADAMAS PHARMACEUTICALS INC shareholders